PRIME NORDIC REPORT for the period of business ending 31 AUG 2019


06 Sep
06Sep

Prime Nordic was incorporated in 2018 as a Nordic investment company. Our investment focus is the Nordic Region and our investment horizon is Long Term. The sectors we are particularly interested in are Energy, Life Sciences and Health Care, Manufacturing and Engineering, Real Estate, Technology and Entertainment.

From outset to the period ending 31 Aug 2019 we have onboarded the following advisors: Avenir, Buzzacott, City One Securities, Faegre Baker Daniels, GCEN, and Mangold. We have launched two PN Bonds and we have invested into 16 companies. These companies are  all listed on Nordic stockmarkets, a majority of them on Nasdaq First North.

For further details please see our website below.

The Prime Nordic portfolio holds shares in the following companies:

Aspire Global
Avensia
Cellink
Cereno Scientific
Diamyd Medical
Fluicell
Invisio Communications
IRLAB Therapeutics
Kambi Group
Kinnevik
Maha Energy
Mangold
Remedy Entertainment
SmartEye
Stillfront
THQ Nordic

Funds raised to date through the two Prime Nordic Bonds in issue have been invested into the portfolio of above companies. Prime Nordic do not charge bondsholders any fees. The initial costs of setting up Prime Nordic including marketing of the bond have been funded by the shareholders.

https://www.primenordic.com

For more information, press only:

Kevin Shinduke Kevin.Shinduke@primenordic.com

Comments
* The email will not be published on the website.